Physician profile
Jeffrey C Webber
NPI 1235242181
$5,409.56
in general payments reported to CMS, 2019-2025
29 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $422 · 2021: $386 · 2022: $962 · 2023: $1,304 · 2024: $2,042 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,420 · Travel and Lodging: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,420.25 |
| Travel and Lodging | $1,105.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,863.30 | 2020-2025 | Ultreon, Thoratec Heartmate 3 Lvas Implant Kit, Optis |
| Pfizer INC. | $496.32 | 2019-2025 | |
| Boston Scientific Corporation | $443.91 | 2022-2025 | Resonate El Icd Vr, Farapulse, Wolverine Coronary Cutting Balloon |
| Abiomed | $436.77 | 2021-2024 | |
| Shockwave Medical, INC | $265.14 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Inari Medical, INC. | $188.60 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.54 | 2022-2024 | Lifevest |
| Novo Nordisk INC | $60.98 | 2023-2024 | Ozempic, Rybelsus |
| Amgen INC. | $60.21 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $59.89 | 2019-2024 | Wainua, Farxiga |
| Inspire Medical Systems, INC. | $49.58 | 2023 | Inspire |
| Terumo Medical Corporation | $46.56 | 2022-2023 | Heartrail, Tr Band |
| Alnylam Pharmaceuticals INC. | $42.45 | 2022-2024 | Onpattro |
| Novartis Pharmaceuticals Corporation | $31.75 | 2019-2023 | |
| Philips North America LLC | $29.30 | 2025 | Ecc Solutions |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $26.91 | 2024 | Injectafer |
| Scpharmaceuticals INC. | $19.31 | 2024 | |
| Chiesi USA, INC. | $18.54 | 2023 | Kengreal, Cleviprex |
| Kiniksa Pharmaceuticals International, Plc | $17.97 | 2024 | Arcalyst |
| Spectrawave, INC | $17.95 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Heartflow, INC. | $17.92 | 2022 | |
| Penumbra, INC. | $16.96 | 2021 | |
| Cardiovascular Systems INC. | $16.60 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.86 | 2024 | Jardiance |
| Cardiva Medical, INC. | $15.10 | 2025 | Optowire |
| Ekos Corporation | $14.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.18 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Webber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.